Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

Cancer Cell

Volumn 2, Issue 5, 2002, Pages 367-376

  Tognon, Cristina ^a   Knezevich, Stevan R ^a   Huntsman, David ^b   Roskelley, Calvin D ^c   Melnyk, Natalya ^a   Mathers, Joan A ^a   Becker, Laurence ^d   Carneiro, Fatima ^e   MacPherson, Nicol ^b   Horsman, Doug ^b   Poremba, Christopher ^f   Sorensen, Poul H B ^a  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF PORTO   (Portugal)

^f HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN TYROSINE KINASE RECEPTOR 3; PROTEIN TYROSINE KINASE; RETROVIRUS VECTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HYBRID PROTEIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR ETS;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; CHILD; CHIMERA; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE FUSION; GENETIC CODE; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; MESENCHYMOMA; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; ONCOGENE; PEDIATRICS; PHENOTYPE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; ANIMAL; BREAST TUMOR; CELL STRAIN 3T3; CHEMISTRY; CHROMOSOME 12; CHROMOSOME 15; COMPARATIVE STUDY; GENE TRANSLOCATION; GENETICS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; RETROVIRUS;

MURINAE; MUS MUSCULUS;

3T3 CELLS; ADOLESCENT; ADULT; AGED; ANIMALS; ARTIFICIAL GENE FUSION; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHILD; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 15; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-ETS; RECEPTOR, TRKC; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RETROVIRIDAE; TRANSLOCATION, GENETIC;

EID: 19044391610     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(02)00180-0     Document Type: Article

References (41)

1. Barbacid, M. (1994). The Trk family of neurotrophin receptors. J. Neurobiol. 25, 1386-1403.
2. Barr, F.G. (1998). Translocations, cancer and the puzzle of specificity. Nat. Genet. 19, 121-124.
3. Bourgeois, J.M., Knezevich, S.R., Mathers, J.A., and Sorensen, P.H.B. (2000). Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumours. Am. J. Surg. Path. 24, 937-946.
4. Buckley, M.F., Sweeney, K.J., Hamilton, J.A., Sini, R.L., Manning, D.L., Nicholson, R.I., deFazio, A., Watts, C.K., Musgrove, E.A., and Sutherland, R.L. (1993). Expression and amplification of cyclin genes in human breast cancer. Oncogene 8, 2127-2133.
5. Cooper, C.S., and Shipley, J.M. (2002). Renal carcinoma. In Translocations in Solid Tumors, C.S. Cooper, ed. (Georgetown, TX: Eurekah.com/Landes), pp. 149-166.
6. Descamps, S., Lebourhis, X., Delehedde, M., Boilly, B., and Hondermarck, H. (1998). Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J. Biol. Chem. 273, 16659-16662.
7. Descamps, S., Pawlowski, V., Revillion, F., Hornez, L., Hebbar, M., Boilly, B., Hondermarck, H., and Peyrat, J.P. (2001a). Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res. 61, 4337-4340.
8. Descamps, S., Toillon, R.A., Adriaenssens, E., Pawlowski, V., Cool, S.M., Nurcombe, V., Le Bourhis, X., Boilly, B., Peyrat, J.P., and Hondermarck, H. (2001b). Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J. Biol. Chem. 276, 17864-17870.
9. Dickson, R.B., and Lippman, M.E. (2001). Molecular biology of breast cancer. In Cancer: Principles and Practice of Oncology, J.V.T. DeVita, S. Hellman, and S.A. Rosenberg, eds. (Philadelphia: Lippincott Williams & Wilkins), pp. 1633-1651.
10. Eguchi, M., Eguchi-lshimae, M., Tojo, A., Morishita, K., Suzuki, K., Sato, Y., Kudoh, S., Tanaka, K., Setoyama, M., Nagamura, F., et al. (1999). Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93, 1355-1363.
11. French, C.A., Miyoshi, I., Aster, J.C., Kubonishi, I., Kroll, T.G., Dal Cin, P., Vargas, S.O., Perez-Atayde, A.R., and Fletcher, J.A. (2001). BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am. J. Pathol. 159, 1987-1992.
12. Ichaso, N., Rodriguez, R.E., Martin-Zanca, D., and Gonzalez-Sarmiento, R. (1998). Genomic characterization of the human trkC gene. Oncogene 17, 1871-1875.
13. Khan, J., Bittner, M.L., Saal, L.H., Teichmann, U., Azorsa, D.O., Gooden, G.C., Pavan, W.J., Trent, J.M., and Meltzer, P.S. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96, 13264-13269.
14. Knezevich, S.R., Garnett, M.J., Pysher, T.J., Beckwith, J.B., Grundy, P.E., and Sorensen, P.H. (1998a). ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 58, 5046-5048.
15. Knezevich, S.R., McFadden, D.E., Tao, W., Lim, J.F., and Sorensen, P.H. (1998b). A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet. 78, 184-187.
16. Ladanyi, M., and Bridge, J.A. (2000). Contribution of molecular genetic data to the classification of sarcomas. Hum. Pathol. 31, 532-538.
17. Lessnick, S.L., Dacwag, C.S., and Golub, T.R. (2002). The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1, 393-401.
18. Liu, Q., Schwaller, J., Kutok, J., Cain, D., Aster, J.C., Williams, I.R., and Gilliland, D.G. (2000). Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia. EMBO J. 19, 1827-1838.
19. Maitra, A., Tavassoli, F.A., Albores-Saavedra, J., Behrens, C., Wistuba, I.I., Bryant, D., Weinberg, A.G., Rogers, B.B., Saboorian, M.H., and Gazdar, A.F. (1999). Molecular abnormalities associated with secretory carcinomas of the breast. Hum. Pathol. 30, 1435-1440.
20. Malaney, S., and Daly, R.J. (2001). The ras signaling pathway in mammary tumorigenesis and metastasis. J. Mammary Gland Biol. Neoplasia 6, 101-113.
21. Mills, G.B., Lu, Y., Fang, X., Wang, H., Eder, A., Mao, M., Swaby, R., Cheng, K.W., Stokoe, D., Siminovitch, K., et al. (2001). The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Semin. Oncol. 28, 125-141.
22. Morrison, K.B., Tognon, C., Garnett, M.J., Deal, C., and Sorensen, P.H.B. (2002). ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation. Oncogene 21, 5684-5695.
23. Oberman, H.A. (1980). Secretory carcinoma of the breast in adults. Am. J. Surg. Pathol. 4, 465-470.
24. Page, D.L., Anderson, T.J., and Sakamoto, G. (1987). Infiltrating carcinoma: major histologic types. In Diagnostic Histopathology of the Breast, D.L. Page and T.J. Anderson, eds. (Edinburgh: Churchill Livingstone).
25. Pear, W.S., Nolan, G.P., Scott, M.L., and Baltimore, D. (1993). Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396.
26. Pierotti, M.A. (2001). Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. Cancer Lett. 166, 1-7.
27. Rabbitts, T.H. (1994). Chromosomal translocations in human cancer. Nature 372, 143-149.
28. Rosen, P.P., and Cranor, M.L. (1991). Secretory carcinoma of the breast. Arch. Pathol. Lab. Med. 115, 141-144.
29. Roskelley, C.D., Wu, C., and Somasiri, A.M. (2000). Analysis of mammary gland morphogenesis. Methods Mol. Biol. 136, 27-38.
30. Rubin, B.P., Chen, C.J., Morgan, T.W., Xiao, S., Grier, H.E., Kozakewich, H.P., Perez-Atayde, A.R., and Fletcher, J.A. (1998). Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am. J. Pathol. 153, 1451-1458.
31. Sandberg, A.A., and Bridge, J.A. (1994). The Cytogenetics of Bone and Soft Tissue Tumors (Austin, TX: R.G. Landes Co.).
32. Sicinski, P., Donaher, J.L., Parker, S.B., Li, T., Fazeli, A., Gardner, H., Haslam, S.Z., Bronson, R.T., Elledge, S.J., and Weinberg, R.A. (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82, 621-630.
33. Somasiri, A., Howarth, A., Goswami, D., Dedhar, S., and Roskelley, C.D. (2001). Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J. Cell Sci. 114, 1125-1136.
34. Sorensen, P.H.B., and Triche, T.J. (1996). Gene fusions encoding chimaeric transcription factors in solid tumours. Semin. Cancer Biol. 7, 3-14.
35. Tavassoli, F.A., and Norris, H.J. (1980). Secretory carcinoma of the breast. Cancer 45, 2404-2413.
36. Teitell, M.A., Thompson, A.D., Sorensen, P.H., Shimada, H., Triche, T.J., and Denny, C.T. (1999). EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts. Lab. Invest. 79, 1535-1543.
37. Tognon, C., Garnett, M., Kenward, E., Kay, R., Morrison, K., and Sorensen, P.M. (2001). The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras- Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation. Cancer Res. 61, 8909-8916.
38. Wai, D.H., Knezevich, S.R., Lucas, T., Jansen, B., Kay, R.J., and Sorensen, P.H.B. (2000). The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 19, 906-915.
39. Wang, T.C., Cardiff, R.D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E.V. (1994). Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369, 669-671.
40. Zhang, X., and Yee, D. (2000). Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Res. 2, 170-175.
41. Zukerberg, L.R., Yang, W.I., Gadd, M., Thor, A.D., Koerner, F.C., Schmidt, E.V., and Arnold, A. (1995). Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol. 8, 560-567.